Navigation Links
Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
Date:10/13/2008

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding potential additional automatic selling and our long-term prospects. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward-looking statements.

Factors that may cause such differences include, among other things: future economic, competitive, reimbursement and regulatory conditions; new product introductions; demographic trends; intellectual property; litigation; financial market conditions; and, future business decisions made by us and our competitors. All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list and description of these and other important risks and uncertainties that may affect our future operations, see Part I, Item 1A - Risk Factors in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which we may update in Part II, Item 1A - Risk Factors in Quarterly Reports on Form 10-Q we have filed or will
'/>"/>

SOURCE Boston Scientific
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...- , - For Effective Literature Search and D...sevier,s biomedical and pharmaceutical abstract an...partnered with QUOSA(TM) to enable,mutual custome...com search,results via a newly established EMBASE... QUOSA Information Manager boosts journal retrie...
(Date:11/28/2008)...cused biopharmaceutical,company Kiadis Pharma ann...of,Clinical Immunology at the University of Perug...collaboration on ATIR(TM), a product in clinical d...onor in a bone marrow transplantation by,preventi...stage leukemia,patients. Under the agreement Prof...
(Date:11/28/2008)...t of PharmSource Information Services Inc., leads ...benefits and challenges of outsourcing pharmaceuti... (PRWEB) November 28, 2008 -- At th... Jim Miller, president of PharmSource Information ...tsourcing to India and China," which explored...
(Date:11/27/2008)...ire-FirstCall/ -- Arpida,announced today that it ...he,key strategic asset Iclaprim. The company says...ive recommendation of the U.S. Food and Drug,Admi...8 regarding the,approval of Iclaprim in the U.S. ...s recommendation the Arpida,board intends to put ...
Breaking Biology Technology:Elsevier's EMBASE.com Partners With QUOSA 2Elsevier's EMBASE.com Partners With QUOSA 3Elsevier's EMBASE.com Partners With QUOSA 4Kiadis Pharma Announces Continued Collaboration With Professor Velardi on its Lead Product ATIR(TM) 2PharmSource President Moderates Videocast on Outsourcing to Asia at AAPS 2Arpida to Restructure and Focus on Key Projects 2
... , , , , High-quality short inte...ficient gene silencing in eukaryotic cell culture ...A. This effect, termed RNA interference (RNAi), en...al genomics studies. Now, QIAGEN offers a custom ,...at includes a range of modifications , and ...
... , , , , For total RNA isolation..., , , , , , ... , RNeasy Protect , ... , , , ... , RNeasy Protect Midi Kit ,...
... , , , , For fast purification o... DNA , , Features and benefits ,...mid DNA , Cleared lysates from up to 2.... , Reduced plasmid purification...ling for small to large culture volumes , ...
... , , , , For ultrafast purificat..., , Features and benefits , ...(Maxi) from harvested culture to , ultr...anol precipitation without centrifugation , ...g precipitation , Up to 200 g (Midi) or...
Other Biology Technology:Custom and library siRNA for efficient gene silencing 2Custom and library siRNA for efficient gene silencing 3Custom and library siRNA for efficient gene silencing 4Custom and library siRNA for efficient gene silencing 5RNeasy Mini, Midi, and Maxi Kits 2RNeasy Mini, Midi, and Maxi Kits 3RNeasy Mini, Midi, and Maxi Kits 4QIAfilter Plasmid Kits 2HiSpeed Plasmid Kits 2
(Date:12/1/2008)...very based on epigenetics (the inheritance of prop...ing cholinea nutrient found in eggs and other food...cancer outcomes for a mother,s offspring. This fin...is the first to link choline consumption during pr...identify possible choline-related genetic changes ...
(Date:12/1/2008)...ow demonstrate how a tight junction protein called...g fit. The study will be published in the December...www.jcb.org ). , Like the rubber coating on a co...f glial cells that spirals around the axons of neu...ent leakage from axons and aids electrical conduct...
(Date:12/1/2008)...e had the common chest wall deformity known as pec... and ability to exercise, according to a study pub...he study, conducted at 11 North American hospitals...atients between the ages of 8 and 21 who had pectu...nts as well. , The results were dramatic. Patien...
(Date:11/30/2008)...tina women have a lower risk of breast cancer than... those with higher European ancestry could be at i...December 1 issue of Cancer Research , a journal o... "We need to study the possible factors that are ...greater risk," said Laura Fejerman, Ph.D., a post-...
Breaking Biology News(10 mins):Eating eggs when pregnant affects breast cancer in offspring 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 3European ancestry increases breast cancer risk among Latinas 2Uroplasty Inc Announces Pricing of a Public Offering of Its Common Stock 6698 1Uroplasty Inc Announces Pricing of a Public Offering of Its Common Stock 6698 2New Book Links Motorcycle Radiation to Cancer Risk 6696 1New Book Links Motorcycle Radiation to Cancer Risk 6696 2China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 1China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 2China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 3China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 4China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 5China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 6China Holdings Inc Announces Its 3rd Biomass Renewable Energy Project 28Power Capacity 3A 50 MW 29 3B Total Potential 3A 150 MW in Biomass Energy P 6694 7Urine Test Results Can Point to Heart Dangers 6692 1Urine Test Results Can Point to Heart Dangers 6692 2
...nta Barbara have made a surprising discovery: phag... The research, which has far-reaching implications...very, is published today online in the Proceedings...agotri, a UCSB professor of chemical engineering, ...will be published in print on March 28. , Phagoc...
... continue to click as Cornell University researche...ecular scale to interact with receptors on cell me...cells -- such as the release of histamines in an a...lular function has long been studied but with ambi...esearchers new tools to understand the role of cel...
...dent known as the colonial tuco-tuco fascinates bi...hreatened species has so little genetic diversity ...ase should have wiped it off the face of the earth... not only managed to survive for thousands of year... it has evolved a complex social structure that,s ...
...st tracking of new drugs for commercial licensing ..., It follows approval of natalizumab, a new drug f... later, after three trial patients developed a lif...talizumab was licensed by the US Food and Drug Adm...sclerosis on the basis of short term results from ...
Other Biology News:'Nano-keys' bind cell receptors and trigger allergic reactions 2'Nano-keys' bind cell receptors and trigger allergic reactions 3Ancient DNA provides clues to the evolution of social behavior 2Ancient DNA provides clues to the evolution of social behavior 3Ancient DNA provides clues to the evolution of social behavior 4
Human Osteocalcin (1-22) mature form. Also reacts with Osteocalcin (1-44) and Osteocalcin (1-49). No reactivity with Bone sialoprotein.
Myt 1 (N-17)
Request Info
...) amide (GLP-1), C-terminal reactive. Cross-reacts...s reactivity with the unamidated forms GLP-1(7-37)... hGLP-2, glucagon, hGIP and VIP.,SPECIES REACTIV...in all mammalian species studied except guinea pig...
Biology Products: